Hormonal manipulation for rising PSA after radical prostatectomy.

Area of Science:

• Oncology
• Urology

Background:

• Prostate-specific antigen (PSA) recurrence post-radical prostatectomy often signifies prostate cancer recurrence.
• Pinpointing the exact site of recurrence (local vs. distant) presents diagnostic challenges.

Purpose of the Study:

• To review the diagnostic modalities for identifying recurrent prostate cancer after surgery.
• To discuss the controversial role and various strategies of hormonal manipulation for rising PSA levels.

Main Methods:

• Review of pathological and clinical features suggesting recurrence.
• Evaluation of radiographic techniques like transrectal ultrasonography and 111indium capromab pendetide scans.
• Discussion of androgen deprivation therapy (ADT) strategies, including maximal blockade, potency-sparing options, and intermittent suppression.

Main Results:

• Diagnostic imaging can aid in localizing recurrence.
• The optimal timing and type of ADT for rising PSA after prostatectomy are debated.
• Maximal androgenic blockade may offer survival benefits in select patients.
• Novel therapies and intermittent ADT aim to balance lifestyle quality with cancer control.

Conclusions:

• Effective management of recurrent prostate cancer requires careful consideration of diagnostic findings and therapeutic options.
• Treatment decisions involve balancing potential survival benefits with patient quality of life.
• Ongoing research seeks to resolve current controversies in managing rising PSA after radical prostatectomy.